Why Bruker Corporation’s (BRKR) Stock Is Up 5.94%
As of Wednesday, August 19, Bruker Corporation’s BRKR share price has surged by 5.94%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Commentary & Analysis
What You Need to Know About Bruker Corporation's Q3 Earnings
Bruker Corporation's fiscal Q3 earnings report was released on Tuesday, August 04. Let's dive in to see if (BRKR) missed or beat analyst's expectations.Jenna Brashear
Why Bruker Corporation’s (BRKR) Stock Is Down 18.58%
As of Tuesday, August 04, Bruker Corporation’s BRKR share price has dipped by 18.58%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Bruker Corporation’s (BRKR) Stock Is Down 18.61%
As of Tuesday, August 04, Bruker Corporation’s BRKR share price has dipped by 18.61%, which has investors questioning if this is right time to buy.Tudor Pop
Is Bruker Corporation (BRKR) Overvalued?
We dive into why Bruker Corporation (BRKR) could be considered overvalued on 2026-07-23, based on AAII’s Value Score and Grade.Rosalio Madrigal
Financial Summary
| Share Statistics | BRKR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,129.4 | $3,076.5 | 76% |
|
| Shares Out (Mil) | 152.3 | 96.5 | 71% |
|
| Institutional Ownership | 74.5% | 90.0% | 45% |
|
| Float (Mil) | 103.7 | 71.5 | 62% |
|
| Beta | 1.28 | 1.22 | 75% |
|
| Avg Daily Volume (000s) | 1,836 | 710 | 81% |
|
| Price Change (52-week) |
72.1% | 89.4% | 86% |
|
| Growth | BRKR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 11.6% | 7.8% | 64% |
|
| Net Income (5yr) | (15.5%) | (13.7%) | 25% |
|
| EPS (5yr) | (16.5%) | 0.7% | 17 |
|
| Dividends (5yr) | 4.6% | 0.0% | 60% |
|
| Cash Flow (5yr) | 107.5% | (15.0%) | 99% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 12 | 13 | 13 | |
| Current EPS | $0.417 | $2.122 | $2.406 | |
| Month Ago EPS | $0.551 | $2.120 | $2.429 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 2 | 1 | 1 | |
| Three Months Ago EPS | $0.548 | $2.118 | $2.417 | |
| Year/Year Chg | (201.0%) | (1,515%) | (1,962%) | |
| Financials | BRKR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,500 | $800 | 69% |
|
| Net Income (TTM) (Mil) | ($71) | ($31) | 13% |
|
| EPS (TTM) | ($0.703) | ($0.300) | 24% |
|
| Operating Cash Flow (TTM) (Mil) | $190 | $47 | 58% |
|
| Net Cash Flow (TTM) (Mil) | $93 | $5 | 76% |
|
| Long-Term Debt (Q1) (Mil) | $1,815 | $270 | 73% |
|
| Enterprise Value (Q1) (Mil) | $9,536 | $3,795 | 73% |
|
| Valuation | BRKR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.84 | 3.68 | 71% |
|
| P/E | na | 39.8 | na |
|
| Dividend Yield | 0.3% | 0.0% | 61% |
|
| PEG (5yr hist) | na | 5.5 | na |
|
| Ratios | BRKR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 48.5% | 47.7% | 60% |
|
| Net Margin | (2.0%) | (3.2%) | 29% |
|
| ROA | (1.1%) | (4.3%) | 36% |
|
| ROE | (3.4%) | (7.9%) | 32% |
|
| Liabilities to Assets | 59.8% | 42.0% | 54% |
|
| F-Score | 5 | 5 | 50% |
|
Bruker Corporation did not pass any screens on 8/20/2026.
